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ABSTRACT 
When sonicated dimyristoylphosphatidylcholine (DMPC) vesicles are 
incubated with erythrocytes, several cell membrane proteins become asso¬ 
ciated with vesicles; these protein-vesicle complexes can be separated 
from the cells by centrifugation (Bouma, e_t a_l. , 1977). One of the 
proteins extracted by vesicle treatment is band 3, the red cell anion 
transport protein. Vesicle-associated band 3 retains its native mem¬ 
brane orientation and its ability to transport anions. Purified band 
3-vesicle complexes can be used to introduce band 3 into cells: if 
these vesicles are incubated with erythrocytes in which anion transport 
has been irreversibly inhibited, a significant percentage of the cells 
recover the ability to transport anions. Recent experiments have shown 
that the protein-vesicle complexes are produced by both cell membrane 
budding and by intermembrane protein transfer (Ott, e_t a_l. , 1981; 
Huestis, personal communication). Reintroduction of band 3 into cells 
appears to occur by intermembrane protein transfer and not by cell- 
vesicle fusion. 
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INTRODUCTION 
The past two decades have seen a remarkable increase in knowledge 
about cell membranes and their components, and an increasing sophistica¬ 
tion in the methods employed to study them. The cell membrane is now 
known not to be just a passive barrier between the external environment 
and the cytoplasm, but an active participant in many aspects of cell 
physiology. 
The model of membrane structure that is most widely accepted is the 
fluid mosaic model proposed by Singer and Nicolson (1972). According to 
this model, the basic structure of the membrane is a phospholipid 
bilayer modified by the presence of membrane-associated proteins (Figure 
1). These proteins can be classified according to their mode of inter¬ 
action with the bilayer. Intrinisic (or integral) proteins interact 
extensively with the hydrophobic acyl chain region of the bilayer. 
These proteins can be dissociated from the membrane only by methods that 
disrupt the integrity of the membrane bilayer (e.g., detergents). The 
other major class of proteins, extrinsic (or peripheral) proteins, bind 
to the surface of intrinsic proteins and do not interact with the 
bilayer. These proteins can be removed from the membrane by conditions 
that leave the membrane bilayer intact (e.g., high ionic strength solu¬ 
tions). Transmembrane proteins, a type of intrinsic protein, completely 
traverse the bilayer and interact with both the external and cytoplasmic 
environments. In the fluid mosaic model, membrane proteins can undergo 
translational motion within the plane of the bilayer (unless restricted 
by interactions with other proteins), but rotation of proteins from one 
side of the membrane to the other does not occur. 
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One of the most powerful tools in the study of cell membranes has 
been the use of model systems composed of synthetic or natural phospho¬ 
lipids. When these lipids are dissolved in aqueous solutions, they 
spontaneously form stable aggregates known as large, multilamellar lipo¬ 
somes (LMLs) (Bangham, e_t aj^. , 1965). These are spheres of lipid 
bilayers arranged concentrically like the layers of an onion, several 
thousand angstroms in diameter (Figure 2). When LMLs are subjected to 
ultrasonication, they become one-bilayer spheres with diameters of about 
250 X known as small, unilamellar vesicles (SUVs) (Huang, 1969) (Figure 
3). Large, unilamellar vesicles (LUVs), up to 800 i? in diameter, can be 
prepared by injection methods that do not involve sonication (Kremer, 
et a 1. , 1977 ; Gerritsen e_t a_l. , 1979) . 
One of the physical properties of purified phospholipid dispersions 
is a phase transition that occurs when they are passed through a criti¬ 
cal temperature range. This transition is accompanied by a decrease in 
bilayer thickness (Chapman, e_t al_. , 1967), an increase in the rotational 
motion of the acyl chains (Trauble, 1972), a decrease in the order para¬ 
meter of electron spin resonance probes (Hubbell and McConnell, 1971), 
and a decrease in apparent microviscosity measured with fluorescent 
probes (Shinitzsky and Barenholz, 1978). The phase transition is thought 
to represent a change from a state in which the phospholipid acyl chains 
are highly ordered (the "solid" or "gel" phase) to a state in which the 
acyl chains are more randomly oriented and the phospholipids can undergo 
rapid diffusional motion within the bilayer plane (the "fluid" or 
"liquid-crystalline" phase) (Trauble, 1972). 
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F igure 1_ 
Figure 2_ 
F igure 3_ 
The fluid mosaic model of membrane structure, a phospholipid 
bilayer with associated intrinsic (A), extrinsic (B), and 
transmembrane (C) proteins. 
Part of a large, multilamellar liposome (LML). 
A small, unilamellar vesicle (SUV). 

Figure 1. 
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LULs composed of pure phospholipids with identical acyl chains, 
such as dimyris toylphosphatidylcholine (DMPC), which has two saturated 
fourteen carbon chains, undergo a phase transition over a narrow (1-2°C) 
temperature range. The phase transition range is broader for disper¬ 
sions of more than one lipid (Shimshick and McConnell, 1973) and for SUVs 
(Lentz e_t a_l. , 1976; Cook et a_l. , 1980). At temperatures below the 
phase transition range, lipid bilayers are in the solid phase; at temper¬ 
atures above the phase transition range, they are in the fluid phase. 
At temperatures within the range, both phases co-exist (Lee, 1977). 
Another important physical property of lipid dispersions is surface 
charge. Dispersions of neutral phospholipids such as phosphatidylcholine 
(PC) and sphingomyelin have no net charge at physiological pH. Acidic 
phospholipids such as phosphatidylserine (PS) and phosphatidylglycerol 
(PG) confer net negative charge to liposomes and vesicles. Negatively 
charged dispersions can also be created by incorporating fatty acids or 
dicetylphospliate into neutral bilayers. No positively charged phospho¬ 
lipids occur naturally, but mixing stearylamine with neutral phospho¬ 
lipids generates positively charged dispersions. 
It is these two physical characteristics, fluidity and surface 
charge, that determine the interactions of model membranes with each 
other and with cell membranes. Vesicles interact with cells in a variety 
of ways. These include: 
1) Adsorption to the cell surface 
2) Exchange of lipid components 
3) Endocytosis of vesicles 
4) Fusion 
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5) Induction of membrane budding 
6) Intermembrane protein transfer 
These interactions are illustrated schematically in Figures 4 through 9. 
Adsorption (Figure 4) refers to vesicles adhering to cell surface 
proteins. The compositions of the cell and vesicle bilayers remain 
unchanged and their structural integrity is maintained. Pagano and 
Takeichi (1977) found that adsorption is the predominate interaction of 
cultured fibroblasts and solid phase PC vesicles. Most of the vesicles 
were released by digesting the cell surface proteins with trypsin. 
Similar results have been obtained examining the interactions of 
positively charged DMPC/stearylamine vesicles with erythrocytes (Martin 
and MacDonald, 1976b; Cook and Huestis, unpublished results). At tem¬ 
peratures below their phase transition range, these vesicles adsorb to, 
and agglutinate the cells. When the temperature is raised above the 
vesicle phase transition range, the vesicles are released from the cells 
and are free to interact with the cell membrane in other ways. If the 
cells are pre-treated with neuraminidase, which cleaves negatively 
charged neuraminic acid residues from cell surface proteins, the vesi¬ 
cles do not agglutinate the cells regardless of the vesicle phase state. 
Adsorbed vesicles appear to leak enclosed low molecular weight con¬ 
tents (Szoka, ejt a_l. , 1979; Renswoude and Hoekstra, 1981). This process 
will be discussed in greater detail below. 
Exchange of lipid components. When vesicles are incubated with 
cells, exchange of lipid occurs, producing the insertion of vesicle phos¬ 
pholipid into the cell membrane (Huang and Pagano, 1975) and vice versa 
(Bouma, 1980). Exchange of cholesterol between cells and vesicles has 
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also been described (Bruckdor f er, et a_l. , 1969; Grunze and Deuticke, 
1974). Lipid exchange occurs between cells and mixed phase vesicles 
(Grant and McConnell, 1973) and between cells and fluid vesicles (Huang 
and Pagano, 1975). Indirect evidence suggests that exchange also occurs 
with solid phase vesicles, but at a much slower rate (Cook e_t a_L. , 1980). 
Lipid exchange can be explained by two mechanisms. In one, lipid 
monomers diffuse through the aqueous medium between cells and vesicles 
without cell-vesicle contact occurring (Figure 5A). In the other mecha¬ 
nism, cells and vesicles transiently collide, and lipid transfer takes 
place through the point of contact between the bilayers (Figure 5B). It 
is unknown which of these two processes occurs (or which predominates if 
both occur). Thermodynamic considerations appear to favor a collisional 
model: the free energy for transfer of phospholipids from a non-polar 
to an aqueous environment--15.1 kcal/mole for dipalmitoylphosphatidy1- 
choline (DPPC) (Smith and Tanford, 1972)--gives the diffusion model a 
much higher energy of activation. Studies examining exchange of lipid 
between DMPC and DPPC vesicles provided results that favor a diffusion 
model (Martin and MacDonald, 1976a). In these experiments, however, 
exchange occurred only with mixed phase vesicles. Lateral phase separa¬ 
tions may lower the free energy for monomer formation. Because cell- 
vesicle lipid exchange occurs with all vesicle phase states, vesicle- 
vesicle exchange may not be an accurate model system for this process. 
Endocytosis of vesicles (Figure 6) is the uptake of vesicles into 
the lysosomal apparatus of cells. This process requires metabolic energy 
and can be inhibited with cytochalasin B or inhibitors of glycolysis and 
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Figure 4 
Figure 5 
Adsorption of vesicles to cell surface proteins. 
Lipid exchange between vesicles and cells: (A) Diffusion 
model, (B) Collision model. 

Figure 5A. 
Figure 5B. 
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respiration used together. Endocytosis occurs regardless of the vesicle 
surface charge or fluidity (Poste and Papahadjopoulos, 1976). 
Fusion (Figure 7) describes the insertion of the vesicle bilayer 
into the cell membrane accompanied by transfer of vesicle contents into 
the cytoplasm. Cell-vesicle fusion has attracted interest as a means of 
introducing drugs, nucleic acids, and other molecules into cells for 
experimental and clinical purposes (for several reviews, refer to 
Gregoriadis and Allison, 1980), and as a model for membrane-membrane 
fusion in vivo. 
Cell-vesicle fusion is difficult to unequivocally demonstrate exper¬ 
imentally. In many systems intended to study fusion, other types of cell- 
vesicle interactions cannot be controlled for. For example, if vesicles 
whose enclosed space contains a label are incubated with cells and some 
of the label becomes associated with the cells, this result could be 
interpreted as indicating that cell-vesicle fusion had taken place. This 
result, however, could also be due to vesicle adsorption or endocytosis. 
Some of these problems have been surmounted by the development of two 
model systems for cell-vesicle fusion: vesicle-vesicle fusion and 
vesicle-induced cell-cell fusion. The reliability of these systems as 
models for cell-vesicle fusion is unclear. Nonetheless, from these 
studies and from the better-controlled attempts to demonstrate cell- 
vesicle fusion, a consistent picture of the conditions necessary for mem¬ 
brane-membrane fusion has emerged. 
Weissman, et a_l. (1977) demonstrated that negatively charged PC/ 
dicetylphosphate vesicles containing horseradish peroxidase could intro¬ 
duce this enzyme into three different cell lines. Delivery was increased 
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Figure 6 
Figure 1_ 
Endocytosis of a vesicle. 
Fusion of a vesicle with a cell membrane. 

Figure 6. 
Figure ?. 

14 
two- to five-fold by the inclusion of lyso-phosphatidylcholine (lyso-PC) 
in the vesicles. Uptake from neutral PC vesicles was not observed. This 
process was not affected by inhibitors of endocytosis. Electron micro¬ 
scopy revealed that the location of the enzyme was cytoplasmic, rather 
than inside adsorbed vesicles. 
Similar results were obtained by Poste and Papahadjopoulos (1976), 
who examined the transfer of enclosed sucrose from vesicles to cells. 
They found that fluid, negatively charged PS/PC vesicles can fuse with 
cell membranes, but neutral and solid phase vesicles (regardless of sur¬ 
face charge) cannot. Endocytosis and cellular uptake of leaked vesicle 
contents were controlled for in these experiments. 
In contrast to these results, several reports have claimed to demon¬ 
strate cell-vesicle fusion using PC vesicles, but these studies have been 
criticized for methodological flaws. Pagano and Huang (1975) claimed 
to observe fusion with PC vesicles, but did not adequately control for 
endocytosis (Poste and Papahad jopoulos, 1976). Weinstein, e_t a_l. (1977) 
and Pagano and Takeichi (1977) studied the interaction of cells with PC 
vesicles whose enclosed volume contained the fluorophore 6-carboxyfluoro- 
scein (6-CF). Due to self-quenching, probe molecules within the vesicles 
exhibited little fluorescence. When the vesicles were incubated with 
cells, cell-associated fluorescence was observed. It was concluded that 
this fluorescence resulted from cell-vesicle fusion and, as a result, 
spreading of the probe throughout the cytoplasm. 
This interpretation was challenged by Szoka, e_t al_. (1979), who 
observed that incubation of cells with vesicles containing 6-CF produces 
an efflux of probe from the vesicles. As noted above, this phenomenon 
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appears to be due to a vesicle permeability defect to small molecules 
that occurs when vesicles associate with cell surface proteins. The 
cell-associated fluorescence seen when vesicles containing 6-CF were 
incubated with cells could have been due to reduced self-quenching pro¬ 
duced by lower probe concentrations within adsorbed vesicles, or to cell 
uptake of free probe released near the cell surface. It was concluded 
that unless efflux of the probe from the adsorbed vesicles could be 
controlled for, this system is unsuitable for studying cell-vesicle 
fusion. 
Vesicle-vesicle fusion has been demonstrated with vesicles contain¬ 
ing PS (Papahad jopoulos, e_t a_l. , 1974; Miller and Racker, 1976), PG 
(Papahadjopoulos, et al_. , 1976b), fatty acids (Kantor and Prestegard, 
1975), and brain gangliosides (Martin and MacDonald, 1976a), but not with 
pure PC vesicles. PC vesicles do form larger structures when incubated 
at temperatures within the phase transition range, but the mechanism of 
this process is intermembrane lipid transfer, not fusion (Papahadjopoulus, 
e_t £1.., 1976a; Martin and MacDonald, 1976a). 
Several investigators have induced cell-cell fusion using vesicles. 
This process presumably involves fusion of a vesicle with the membranes 
of two cells. Papahad jopoulos e_t aj^. (1973) produced extensive cell-cell 
fusion with fluid PS and PS/PC vesicles. Neither PC vesicles nor solid 
phase vesicles induced fusion. Martin and MacDonald (1976c) observed 
some cell-cell fusion when incubated with vesicles containing lyso-PC or 
stearylamine, and extensive fusion with vesicles containing both. Under 
the conditions described, these vesicles were in a fluid phase state 
(Cook and Huestis, unpublished observations). 
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To summarize, the bulk of data obtained from experiments studying 
cell-vesicle fusion, vesicle-vesicle fusion, and vesicle-induced cell¬ 
cell fusion indicates that fluid vesicles with a positive or negative 
surface charge and/or containing lyso-PC can fuse with cell membranes, 
but neutral PC vesicles and solid phase vesicles cannot (Poste, 1980). 
Induction of membrane budding and intermembrane protein transfer. 
These two processes will be discussed together since both happen simul¬ 
taneously in the same experimental system. When DMPC vesicles are mixed 
with erythrocytes, several membrane proteins become associated with the 
vesicles. These protein-vesicle complexes can be separated from the 
cells by centrifugation (Huestis, 1976). If the protein-containing ves¬ 
icles are analyzed by ultracentrifugation on sucrose gradients, two 
vesicle populations are observed (Huestis, personal communication). One 
of the populations contains vesicles whose lipid composition is similar 
to that of the red cells and whose enclosed volume contains hemoglobin 
(Ott, e_t a_l. , 1981). The lipid composition of the second population is 
almost entirely DMPC. These vesicles contain no hemoglobin (Huestis, 
personal communication). Aside from hemoglobin, the protein composition 
of these two groups of vesicle-protein complexes is identical. 
The first group of vesicles appears to be produced by budding from 
the cell membrane. Mixing fluid DMPC vesicles with red cells produces 
an almost immediate cell shape transformation from the normal disco- 
cyte conformation to an echinocyte (Ott, <2t al^. , 1981). With further 
incubation, the cells become spherocytes (Bouma, 1980). Scanning elec¬ 
tron microscopy of the echinocytes reveals vesicles budding from the 
tips of the echinocytes (Ott, £t^ al_. , 1981). 
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ATP depletion of erythrocytes also produces a discocyte-to- 
echinocyte shape change and the formation of membrane buds (Lutz, e_t a 1. , 
1977; Sheetz and Singer, 1977). Vesicle treatment of red cells does not 
produce ATP depletion, so these two similar processes appear to occur 
by different mechanisms (Ott, e_t al. , 1981). 
It has been proposed that vesicle-induced budding is the result of 
lipid transfer from the vesicles to the outer monolayer of the cell mem¬ 
brane (Ott, e_t al. , 1981). The resulting overabundance of lipid in the 
outer monolayer relative to the inner monolayer causes the membrane to 
"buckle" into an echinocyte conformation. In the tips of the echino- 
cytes, two segments of the inner monolayer come into contact. The inner 
monolayer of the red cell contains all of the membrane PS (Verkleij, et_ 
a 1. , 1973). Therefore, echinocyte formation brings two PS-containing 
membranes into contact. These two membranes fuse, and the vesicle so 
formed dissociates from the cell. This mechanism is illustrated in 
Figure 8. 
The second group of vesicle-protein complexes is created by a com¬ 
pletely different process. Analysis of the lipid composition and 
enclosed contents of these vesicles reveals that they are the original 
DMPC vesicles that have acquired proteins from other membranes (Newton 
and Huestis, personal communication). This intermembrane protein trans¬ 
fer, just like lipid exchange (see above), could occur by either of two 
mechanisms: one is diffusion of proteins through the aqueous medium 
between the membranes; the other, through membrane-membrane collisions 
with transfer of proteins through the area of contact. The identities 
of several of the transferred proteins are known (see below). All are 
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Figure 8: Vesicle-induced membrane bud formation: treatment of erythro¬ 
cytes with DMPC vesicles changes the cells from normal disco- 
cytes (A) to echinocytes (B); in the tips of the echinocytes 
(C), the inner monolayers fuse, creating a vesicle-bud that 
dissociates from the cell membrane (D). 
I 
Figure 8. 
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intrinsic proteins. Several are transmembrane proteins. Therefore, it 
is extremely unlikely that these proteins would spontaneously dissociate 
from a lipid bilayer, and transfer of these proteins probably occurs 
through membrane-membrane collisions. 
The "transfer vesicles" appear to acquire proteins from both the 
"vesicle-buds" and the cell membrane. If DMPC vesicles are mixed with 
vesicle-buds, intervesicle protein transfer occurs, and a population of 
transfer vesicles is formed. Likewise, incubation of DMPC vesicles with 
cells that have completed the discocyte-to-echinocyte shape transforma- 
tion--and have thus completed vesicle budding--a Iso produces transfer 
vesicles (Huestis, personal communication). The percentage of transfer 
vesicles that acquire proteins from cells versus the percentage that 
acquire proteins from vesicle-buds in unknown. Protein transfer between 
cells and vesicles and between vesicles and other vesicles is shown in 
Figure 9. 
Several of the cell proteins that are "extracted" into vesicle-buds 
and transfer vesicles have been identified. One is the red cell acetyl¬ 
cholinesterase (AChE), an intrinsic protein (Ott, e_t £1^. , 1975) that can 
be removed with greater than 907o efficiency using fluid DMPC vesicles. 
Extracted AChE retains its native orientation and function in the vesicle 
membrane (Bouma, e_t aJL. , 1977). Glycophorin, a glycosylated transmem¬ 
brane protein (Marchesi, 1979), is also removed (Ott, et al. , 1981). 
One extracted protein appears to be associated with a red cell sodium 
channel similar to ion channels found in nerve and muscle cells (Huestis, 
1977). Another migrates on SDS-polyacrylamide gels with an apparent 
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Figure 9 Intermembrane protein transfer of an 
(A) Protein transfer between vesicles 
(B) Protein transfer from a cell to a 
Intrinsic protein. 
vesicle 

A 
B 
Figure 9 
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molecular weight of 95 kilodaltons, similar to that of band 3, the red 
cell anion transport protein (Ott, et a_1. , 1981). 
If protein transfer from cells to vesicles takes place, the possi¬ 
bility of the reverse process, vesicle to cell transfer, occurring is 
raised. Bouma e_t a_l. (1977) attempted to demonstrate delivery of extrac¬ 
ted proteins labelled with radioactive iodine back into cells using 
vesicles. Some of the label became associated with the cells, but this 
result could have been due to either protein transfer or to vesicle 
adsorption. Definitive proof of the ability of vesicles to transfer pro¬ 
teins to cells requires that a vesicle-associated intrinsic protein can 
be delivered to the cell membrane and express its functional activity in 
the cell membrane, and that the function of the transferred protein 
involves the alteration of intracellular properties. Of the proteins 
that are known or believed to be transferred from red cells to vesicles, 
only one is suitable for this purpose: band 3. The goal of the experi¬ 
ments described in this thesis is to determine if band 3 is one of the 
proteins extracted from erythrocytes, and, if so, to demonstrate that 
this protein can be reintroduced into cells. 
Band 3 (nomenclature of Fairbanks, e_t al. , 1971) is the major 
intrinsic protein of the red cell membrane, representing approximately 
257o of the total membrane protein. When analyzed by SDS-polyacrylamide 
gel electrophoresis, it appears as a broad band spanning the 85 to 110 
kilodalton molecular weight range (Fairbanks, e_t a_l. , 1971). Band 3 
appears to have several physiological functions, the most important of 
which is anion transport across the membrane. 
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The function of anion transport in the erythrocytes is to allow 
bicarbonate, formed from tissue carbon dioxide by red cell carbonic 
anhydrase, to distribute rapidly into the plasma. This prevents the 
accumulation of bicarbonate in the red cells and increases the ability 
of blood to transport carbon dioxide from peripheral tissues to the lungs. 
Transport occurs by one-for-one exchange of anions across the red cell 
membrane: in the tissue capillaries, intracellular bicarbonate is 
exchanged for extracellular chloride; in the lungs, the reverse process 
takes place. Band 3 also mediates unidirectional anion fluxes across 
the membrane. The rate constant for unidirectional transport, however, 
is several orders of magnitude smaller than that for exchange. Anion 
transport is driven by anion concentration gradients across the membrane 
and does not require metabolic energy (Cabantchik, et aj^. , 1978). This 
system will transport a variety of anions, including halides, phosphate, 
sulfate, and some organic acids, although at different rates. The most 
rapid rate of transport occurs with chloride exchange, which has a half- 
life of about 50 milliseconds at physiological temperatures (Brahm, 
1977) , far less than the amount of time blood cells spend passing 
through tissue and lung capillary beds. 
The study of anion transport in erythrocytes has been facilitated 
by the development of chemical probes that bind to band 3 and inhibit 
anion transport. The most widely-used of these probes have been isocyano 
derivatives of sulfonic acid, such as diisothiocyanostilbene disulfonic 
acid (DIDS). Useful characteristics of DIDS include (Cabantchik, e_t a 1. , 
1978) : 
1) very slow permeation limits its activity to the outer surface of 
the membrane 

25 
2) full, irreversible (covalent) inhibition of anion transport is 
produced by DIDS treatment under mild conditions 
3) interference with no other transport or enzymatic properties of 
the red cell membrane 
4) at maximal inhibitory concentrations, more than 90% of DIDS is 
bound to band 3 
Measurement of labelled DIDS binding to red cells has allowed the number 
of band 3 molecules to be estimated at about 10^ per cell (Ship, e_t a 1. , 
1977) . 
Other useful information about band 3 has been obtained by studying 
the products of its enzymatic digestion. Band 3 is a transmembrane pro¬ 
tein that crosses the membrane at least twice: both the amino and car- 
boxy terminals are on the cytoplasmic side of the membrane (Markowitz 
and Marchesi, 1981). Digestion with chymotrypsin at the external surface 
produces two membrane-bound segments with molecular weights of roughly 
65 and 30 kilodaltons, which contain the amino and carboxy terminals, 
respectively (Drickamer, 1976). Treatment with trypsin at the inner mem¬ 
brane surface produces two large fragments. One is a membrane-bound seg¬ 
ment with a molecular weight of about 55k; the other, a cytoplasmic 
segment whose molecular weight is roughly 40k. Smaller products of the 
digestion of the 40k segment are also produced (Jenkins and Tanner, 1977). 
The membrane-bound tryptic fragment, which contains the carboxy terminal, 
represents the segment of the protein that transports anions (Lepke and 
Passow, 1976). The cytoplasmic proteins, including: glyceraIdehyde 3-P 
dehydrogenase (Yu and Steck, 1975), aldolase (Strapazon and Steck, 1977), 
hemoglobin (Sayare and Fikiet, 1981), and ankyrin (band 2.1) (Bennett 
and Stenbuck, 1979, 1980; Hargreaves, et al., 1980), 
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The DIDS binding site is on the 65k chymotryptic and 55k tryptic 
fragments (Drickamer, 1976). Vigorous chymotryptic digestion at both 
faces of the membrane produces a 15k transmembrane segment that can be 
cleaved by CNBr into three fragments of 7, 4, and 4 kilodaltons. The 
DIDS binding site is located on the middle 4k segment. Since the DIDS 
binding site is located near the outside face of the membrane, it appears 
that the 15k segment crosses the bilayer at least three times (Ramjeesingh, 
et a 1., 1980). A schematic representation of the membrane orientation of 
band 3, based on the data presented above, is shown in Figure 10. 
Band 3 contains five reactive sulfhydryl groups, all on the cyto¬ 
plasmic side of the membrane (Rao, 1979). Three of these are located on 
the cytoplasmic tryptic fragment; the remainder, on the cytoplasmic car- 
boxy terminal segment (Rao and Reithmeier, 1979). One of these sulf¬ 
hydryl groups can be cross-linked to a sulfhydryl group on another band 
3 molecule to form a dimer with a molecular weight of about 190k (Steck, 
1972). Largely for this reason, band 3 was originally believed to be a 
dimer in the red cell membrane. More recent data, however, suggest that 
it may instead exist as a tetramer (Nigg and Cherry, 1980). 
As noted above, one of the cytoplasmic proteins that binds to band 
3 is ankyrin. Ankyrin is one of four extrinsic proteins (the others: 
spectrin, actin, band 4.1) that compose the red cell cytoskeleton, a 
filamentous matrix of proteins lining the inner surface of the red cell 
membrane. The cytoskeleton appears to determine the structural stabil¬ 
ity of the red cell (Lux, 1979). Band 3 may "anchor" the cytoskeleton 
to the cell membrane. Recent experiments suggest that band 3 does not 
move freely within the membrane, but that its lateral mobility is 
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Figure 10: The membrane conformation of band 3. The sites of 
by chymotrypsin (at the outer surface) and trypsin 
DIDS binding site are shown. 
cleavage 
and the 

Chymotrypsin X 
NH< 
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determined by its interactions with the cytoskeleton (Nigg and Cherry, 
1980; Golan and Veatch, 1980; Hargreaves, et a_l., 1980). 
To summarize, band 3 is an interesting protein both for its physio¬ 
logic function as a transport protein and for its putative role in con¬ 
tributing to the structural stability of the cell. As the most abundant 
membrane protein in the most easily studied human cell line, it provides 
a useful model for developing concepts and techniques that may be 
applicable to less accessible transport and structural proteins. 
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MATERIALS AND METHODS 
Materials . Dimyristoylphosphatidylcholine (DMPC), bovine chymotrypsin, 
o-phenanthroline, and alpha-methyl mannoside were products of Sigma Chem- 
32 36 ical Company. Na P0 was purchased from New England Nuclear, NaJDCl 
3 4 
from ICN, DIDS from Aldrich, eosin maleimide (eosin MA) from Molecular 
Probes, and Concanavalin A-Sepharose 4B (Con A-Sepharose) from Phar¬ 
macia. Human erythrocytes were obtained from adult volunteers and used 
within 36h of collection. Unless otherwise stated, experiments were con¬ 
ducted in phosphate-buffered saline (PBS) containing 150mM NaCl, 7.5mM 
Na HPO , 5mM KC1, ImM MgSO , and lOmM glucose, adjusted to pH 7.4 with 
2 4 4 
IN HC1. 
Methods 
Preparation of phospholipid vesicles. DMPC (24mM) was suspended in buffer 
by mixing on a vortex stirrer. The lipid suspensions were sonicated for 
30 min at 40 °C in a test tube (13 X 100 mm) suspended in a Heat Systems 
Ultrasonics model 9H bath sonicator filled to a depth of 3.6 cm with a 
solution of a few grams sodium dodecyl sulfate (SDS) in water. Vesicles 
prepared in this manner are monodisperse (250 to 300 $ in diameter) and 
unilamellar (van der Bosch and McConnell, personal communication). Thin 
layer chromatography showed that they contained less than 0.1% lyso-PC 
(Bouma, e_t a_l., 1977). 
Extraction of erythrocyte membrane proteins. Freshly-drawn human ery¬ 
throcytes were separated from plasma by centrifugation, then washed 
three times by suspension in 4 volumes of 0.15M NaCl, followed by centri¬ 
fugation. A final wash in buffer followed. 
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Aliquots of packed cells were warmed to 37 °C. Phospholipid vesi¬ 
cles were added in a volume equal to that of the cells. Incubation was 
carried out at 37 °C in an agitating water bath for 45 min unless other¬ 
wise noted. The cells were then pelleted by centrifugation at 3000 X g 
for 5 min, and the vesicle supernatant was again centrifuged at 3000 X g 
for 5 min to eliminate any contaminating cells. Incubation of vesicles 
with resealed ghosts were performed in the same manner. 
Ana lysis of band 3_ or ientation and quaternary s trueture . Washed cells 
were suspended to a hematocrit of 507, in buffer. Chymotrypsin was added 
to yield a concentration of 200 qg/ml, and the suspension was agitated 
gently at 22 °C for 14h. The cells were pelleted and washed three times 
by resuspension in ten volumes of PBS. The cells were then incubated 
with vesicles as above, and cell and vesicle fractions were separated by 
centrifugation. Concurrently, undigested cells were incubated with 
vesicles. After separation from the cells, half of the vesicle fraction 
was treated with chymotrypsin (200 *|g/ml) for lh at 22 °C. Chymotrypsin 
was removed from the vesicle sample by passing the sample through a 
Sepharose 4B column (0.5 X 5 cm). Stroma were prepared from the normal 
and chymotrypsin-digested cells by lysis and repeated washings with 5mM 
Na2HP0^, pH 8.0. Stroma and vesicle samples were analyzed by SDS- 
polyacrylamide gel electrophoresis (Ames, 1974). 
For Cu(II)-phenanthroline cross-linking experiments, red cell 
ghosts were prepared as described by Steck and Kant (1974). Unsealed 
ghosts were incubated for 30 min at 0 °C in ten volumes of 5mM Na2HP0^, 
pH 8.0, containing 50 CuSO^ and 200 vjM o-phenantroline. The membranes 
were pelleted, washed once, and resealed by suspension in 10 volumes of 
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5mM Na^PO^ plus 5 volumes of a solution containing 260mM KC1, 18mM NaCl, 
0.875mM MgC^, 4mM Na2HP0^, 0.263mM CaCl2, and ImM Na2ATP. After 5 min 
at 0 °C, the suspension was incubated lh at 37 °C. The resealed ghosts 
were pelleted, washed once in PBS, and incubated with vesicles as above. 
Uncross-linked, resealed ghosts were prepared and incubated with vesicles 
also. Ghosts and vesicles were subjected to gel electrophoresis under 
reducing and non-reducing conditions. 
Vesicle anion permeability. Anion flux into vesicles was measured by a 
modification of the method of Wolosin, ej: a_l. (1977). After incubation 
with cells, 0.5 ml of vesicles was added to 0.5 ml of PBS or PBS made 
32 
2mM in DIDS . Flux measurements were initiated by pipetting3qCi Na^ PO^ 
into the rapidly stirred solution at 25 °C. At specified intervals, 
100 ql aliquots were removed and anion flux quenched by the addition to 
an equal volume of 2mM DIDS in PBS at 0 °C. Aliquots (50 ql) of these 
samples were applied to 1.5 ml DEAE-Sephadex A-25 columns at 4 °C. 
Vesicles were eluted by addition of a precalibrated volume of PBS/2mM 
32 -3 
DIDS that eluted the vesicles but not free PO^ . Eluted vesicles 
were collected directly into scintillation vials, dissolved in Aquasol, 
and analyzed by liquid scintillation counting. 
Protein transfer from vesicles to cells. Band 3-vesicle complexes were 
isolated from the vesicle supernatant by a modification of the technique 
of Ross and McConnell (1977). Vesicle superna'tants were applied to a 
Con A-Sepharose column (0.9 X 30 cm). The resin was washed with at 
least 3 column volumes of a buffer containing 0.2M NaCl, lOmM HEPES, 
0.7mM each of CaC^, MnC^, and MgC^, and 0.57o NaN^ . The band 3-vesicle 
complexes were eluted with a similar buffer containing 0.1M NaCl and 
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0.1M alpha-methyl mannoside. The band 3-vesicle complexes were divided 
into two fractions. One fraction was treated with 0.7mM eosin MA for lh 
in the dark at 22 °C to inhibit vesicle-bound band 3 (Nigg and Cherry, 
1979). (Eosin MA was used as a covalent band 3 inhibitor because, 
unlike DIDS, it is monovalent and should not crosslink and aggregate 
band 3-vesicle complexes). Unbound eosin MA was removed by passing the 
sample through a PD-10 column. Washed red cells were incubated with an 
equal volume of 0.7mM eosin MA in PBS for 3h in the dark at 22 °C, and 
isolated by centrifugation and washings in PBS. Samples of eosin- 
inhibited cells were incubated with a) isolated band 3-vesicle complexes, 
b) eosin-inhibited band 3-vesicle complexes, and c) PBS, each vesicle 
sample having a phospholipid concentration of 0.35mM. Control samples 
of untreated red cells were incubated simultaneously, suspended in 
either PBS or PBS containing pure DMPC vesicles in the same concentration 
as in the experimental samples. All cell samples were pelleted, washed 
three times in PBS, and used immediately for chloride flux measurements. 
Measurements of chloride flux into ce11s. Red cells (0.5 ml) were sus¬ 
pended in rapidly stirred PBS (4.5 ml) on ice. Na^Cl (1„9 ^Ci) was 
added. At specified intervals, 0.5 ml aliquots of the suspension were 
pipetted into 0.2mM DIDS in PBS (0.9 ml). The cells were pelleted and 
washed by resuspension in 1.0 ml 0.2mM DIDS in PBS. Aliquots (20 J4I) 
of packed cells were lysed in 0.5 ml water, dissolved in 10 ml Aquasol, 
and analyzed by liquid scintillation counting. 
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RESULTS 
Extraction of band 3_ from erythrocytes using DMPC vesicles 
Figures 11 through 13 are photographs of SDS-polyacrylamide gels 
performed with vesicles and washed stroma. 
Figure 11 demonstrates the appearance of extracted cell proteins 
into the vesicles. Lane 1 contains washed stroma and demonstrates the 
major protein bands of the membrane. Lanes 2 through 6 reveal the pro¬ 
teins bound to vesicles after 0, 15, 30, 45, and 60 minutes of incuba¬ 
tion with cells at 37 °C. The most prominent vesicle-associated protein 
co-migrates with band 3 and shows the same diffuse distribution around 
95k daltons. Bands 1 and 2 do not appear in the vesicle fraction until 
significant cell lysis has occurred. 
The effects of chymotrypsin treatment of the 95k protein are seen 
in Figure 12. Digestion of cell membranes or vesicle-protein complexes 
results in the disappearance of band 3 and the appearance of a band at 
about 65k daltons (lanes 4 and 3, respectively). If vesicles are incu¬ 
bated with chymotrypsin-treated cells, the same 65k dalton band appears 
in the vesicles (lane 6). 
The gel in Figure 13 contains proteins of red cell stroma cross- 
linked by Cu(II)-phenanthroline and analyzed by electrophoresis in the 
absence (lane 4) and presence (lane 9) of ^ -mercaptoethanol. Band 3 is 
replaced by higher molecular weight bands unless the sample is reduced. 
Vessicles incubated with cross-linked, resealed ghosts contain no band 3 
(lane 5). When this sample is reduced (lanes 10 and 11), band 3 appears 
and higher molecular weight bands disappear. Vesicle-bound band 3 
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Figure 11: Sodium dodecylsulfate polyacrylamide gel (10%) of erythro¬ 
cyte membranes (lanes 1 and 8) and phospholipid vesicles 
incubated with cells for 0 (lane 2), 15 (lane 3), 30 (lane 
4), 45 (lane 5), and 60 (lane 6) minutes at 37 °C. Prior to 
electrophoresis, vesicles were separated from unbound protein 
(lane 7) by passage through Sepharose 4B. Bands 1 and 2 do 
not appear in the vesicles until significant hemolysis has 
occurred (lane 6). 
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Figure 12: Polyacrylamide gel of normal and chymotrypsin-treated band 3 
in cells and vesicles. Standards (lanes 1 and 6), normal 
ghost membranes (lane 2), vesicle extract of normal cells 
(lane 3), chymotrypsin-treated extract of normal cells 
(lane 4), chymotrypsin-treated ghosts (lane 5), and vesicle 
extract of chymotrypsin-treated cells (land 6). 

12 3 4 5 6 7 
daltons 
14 
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Figure 13: Polyacrylamide gel of normal and Cu(II)-phenanthroline cross- 
linked band 3 in cells and vesicles. Normal ghosts (lane 1), 
vesicles incubated with normal ghosts (lane 2), Cu(II)- 
phenanthroline treated vesicle extract of normal ghosts 
(lane 3), Cu(II)-phenanthroline treated ghosts (lane 4), 
and vesicle extract of Cu(II)-phenanthroline treated ghosts 
(lane 5). Lanes 6-10 show the same samples in the same 
order, subjected to electrophoresis in the presence of 
/3 -mercaptoethanol. 

12 3 4 5 67 89. MU 
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could also be cross-linked (lane 3); again, this was reversed by treat¬ 
ment with,/? -mercaptoethanol (lane 8). 
Anion permeabi1ity of band 3-vesicle complexes 
After incubation with erythrocytes, vesicles exhibited anion uptake 
(Figure 14). Anion uptake was not observed in the presence of DIDS or 
in vesicles not exposed to cells. These results indicate that band 3 
retains the ability to transport anion across the vesicle membrane. More¬ 
over, since anion uptake into the vesicles is quantitatively inhibited 
by DIDS, the protein must be in its native orientation. 
Trans fer of band 3_ from ves ic les to ce 11s 
Figure 15 presents the protocol for examining transfer of band 3 
from vesicles to cells. Erythrocytes in which anion transport had been 
irreversibly inhibited with eosin MA were incubated with: a) band 3- 
vesicle complexes purified on a Con A-Sepharose column, b) purified band 
3-vesicle complexes that had been treated with eosin MA, c) PBS. After 
the incubations, the chloride uptake of the cells was measured. These 
results are shown in Figure 16. 
Cells treated with eosin MA exhibited a rate of chloride uptake that 
was 1.37, of uptake into treated cells, i.e., uptake was inhibited almost 
997o by treatment with eosin MA. Incubation of inhibited cells with 
eosin-treated vesicles produced no increase in chloride uptake. Incu¬ 
bation of inhibited cells with functional band 3-vesicle complexes, how¬ 
ever, produced a small, but significant increase in chloride uptake 
(t <0.01) (Calculation performed with Student’s t-test using triplicate 
determinations of chloride uptake at 15 min). In all cases, chloride 
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Figure 14: 32 o JZ,P-phosphate flux into protein-vesicle complexes at 25 °C 
in the absence (O) and presence (#) of DIDS . 
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Figure 15: Protocol for delivery of band 3 
transport has been irreversibly 
into red cells whose anion 
inhibited with eosin MA. 
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F igure 16: Chloride uptake into cells at 0 °C. Normal erythrocytes (O), 
after incubation with DMPC vesicles (V); eosin MA inhibited 
cells after incubation with functional band 3-vesicle com¬ 
plexes (A), eosin MA inhibited band 3-vesicle complexes 
(□), or PBS (0)- Filled symbols show chloride uptake into 
the same samples in the presence of 0.2mM DIDS. 
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uptake was blocked quantitatively (> 99.98%) by the presence of 0.2mM 
DIDS during uptake measurements. All observed anion uptake, therefore, 
was mediated by band 3. 
The fraction of cells in the samples containing one or more func¬ 
tional anion transport proteins can be estimated by fitting plots of In 
(cpmC00) - cpm(t)/cpm( oo)) versus time for arbitrary values of cpm( 1X1) . 
For the inhibited cells treated with functional or inhibited band 3- 
vesicle complexes, the best fits for this function were obtained when 
cpm(°o ) corresponded to 55% and 24%. of the cells, respectively. There¬ 
fore, when eosin-inhibited cells were treated with functional band 3- 
vesicle complexes, at least 31%, of the cells acquired band 3 from the 
vesicles. 
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DISCUSSION 
The experiments described in the results section were performed 
before the heterogeneity of vesicle-protein complexes produced by incu¬ 
bation of erythrocytes with DMPC vesicles was appreciated. The results 
shown in Figures 11 through 14 were obtained with vesicle samples that 
contained both transfer vesicles and vesicle buds. These experiments 
have recently been repeated with pure transfer vesicles and vesicle buds, 
and identical results were obtained with both samples (Newton and 
Huestis, personal communication). 
Analysis of the purified band 3-vesicle complexes eluted from Con A- 
Sepharose columns has revealed that these vesicles are pure transfer 
vesicles (Newton and Huestis, personal communication). Therefore, the 
experiments examining vesicle-to-cell protein transfer were performed 
with transfer vesicles, not a mixture of transfer vesicles and vesicle 
buds . 
These experiments demonstrate the utility of using a transport pro¬ 
tein to demonstrate vesicle-to-cell protein transfer. The number of 
band 3 copies transferred from vesicles tro cells in these experiments 
is small relative to the total number of copies in normal cells: incu¬ 
bation of functional band 3-vesicle complexes with inhibited cells pro¬ 
duced only a 15% increase in the rate of chloride flux (from 1.3% to 
1.5% of normal). Since the percentage of cells with at least one func¬ 
tional anion transport protein was increased 130%, from 24% to 55%, how¬ 
ever, the increase in chloride flux was statistically significant. 
Therefore, this method of examining protein transfer to cells is 
extremely sensitive. These results could not be due to adsorption of 
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band 3-vesicle complexes to cells. If the vesicles were merely adsorbed 
to the cells, cells treated with functional band 3-vesicle complexes 
would show a much smaller increase in anion uptake because the enclosed 
volume of the vesicles is more than two orders of magnitude less than 
that of the cells. 
These results could also be produced by fusion of band 3-vesicle 
complexes with cells. This possibility is unlikely, however, since the 
vesicles used in the vesicle-to-cell transfer experiments were transfer 
vesicles, which do not contain PS. It is possible that some other lipid 
or protein component in the transfer vesicles can induce cell-vesicle 
fusion. If this were true, though, vesicle buds and transfer vesicles 
would be expected to fuse with each other, which the}'- do not. These 
observations do not exclude the possibility of cell-vesicle fusion, but 
current data is most consistent with an intermembrane transfer mechanism. 
Another system in which protein transfer between membranes has been 
described is the transfer of cytochrome b^ between vesicles (Roseman, e_t 
a 1. , 1977; Enoch, e_t a_l. , 1977). This phenomenon has been shown to 
occur by the protein diffusing through solution between membranes, 
rather than by membrane-membrane collisions (Leto, £t a 1., 1980). Cyto¬ 
chrome b5 is much less hydrophobic than band 3 and is not a transmem¬ 
brane protein. Considering the extremely hydrophobic nature of band 3 
segments associated with the cell membrane (Steck, 1978), it is most 
unlikely that transfer of band 3 between membranes could occur by the 
protein diffusing through an aqueous solution. 
It may seem paradoxical that band 3, which is thought to be bound 
to the red cell cytoskeleton, could be so easily removed from the cell 
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by budding and transfer. The average number of band 3 copies removed 
from each cell can be crudely estimated based on measurements of the 
relative areas of the band 3 and AChE peaks on densitometer scans of poly 
acrylamide gels performed on vesicle extracts; determination of the per¬ 
centage of AChE activity removed from cells by vesicles; and estimation 
of the number of AChE copies to be 10^ per cell (Sihotang, 1974). Using 
this method, the number of band 3 copies removed per cell is 10^, or 10% 
of the total. Only about 15-207> of band 3 appears to be directly bound 
to ankyrin (Nigg and Cherry, 1980; Hargreaves, e_t al_. , 1980). If band 3 
is assumed to be a tetramer, then approximately 60-80% would be anchored 
to the cytoskeleton. Therefore, the observed amount of band 3 extraction 
into vesicles could occur without requiring the dissociation of any band 
3 from the cytoskeleton. Cytoskeletal binding may, in fact, represent 
the reason that removal of band 3 is inefficient relative to AChE removal 
Much still needs to be learned about intermembrane protein trans¬ 
fer, particularly the factors that determine the specificity and kinetics 
of the process. Unfortunately, the study of protein transfer from ery¬ 
throcyte membranes to vesicles is complicated by the simultaneous occur¬ 
rence of membrane budding. For reliable information to be gained about 
cell-to-vesicle transfer, a system must be found in which budding does 
not take place . 
The occurrence of intermembrane protein transfer in vitro raises 
the question of whether this phenomenon also occurs in any biological 
systems. No such process has yet been described, but intermembrane pro¬ 
tein transfer is an attractive mechanism for membrane assembly. 
In the laboratory, protein transfer could become a powerful tool in 
studying membrane physiology in normal and diseased cells. Vesicle-to- 
cell transfer is a uniquely "non-invasive" technique for altering the 
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properties of a cell: it could be used to introduce a foreign protein 
into a cell, or a normal protein into a cell in which that protein is 
defective. Hopefully, the techniques employed in this thesis will be 
useful in learning more about intermembrane protein transfer, and in 
applying this interesting phenomenon to the study of other systems. 
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